India covid-19 Coronavirus Merck India

Merck says its COVID-19 drug should be effective against any variant

Reading now: 490
www.livemint.com

BENGALURU : Merck & Co Inc's experimental COVID-19 drug molnupiravir should have similar activity against any new coronavirus variant, a company executive said on Tuesday.

The drug, developed along with Ridgeback Biotherapeutics, shows antiviral properties against coronavirus variants such as the Delta variant, Daria Hazuda, vice president of Merck's infectious diseases and vaccines division, said.

Hazuda's comments were part of a general presentation and not specific to the Omicron coronavirus variant.Never miss a story!

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA